Robert M. Cuddihy

Background

About Robert M. Cuddihy

Physician-executive with 30+ years bridging the full continuum of medicine — from frontline clinical endocrinology at Mayo Clinic, Harvard, and Dartmouth to C-suite and VP leadership at Crinetics Pharmaceuticals, Amgen, J&J Janssen, Sanofi, and as CEO of a gene therapy biotech.My career is defined by three pillars that rarely coexist in one leader: Clinical Depth: Board-certified Endocrinologist (ABIM, F.A.C.E.) with 25+ years of active practice, academic appointments at Mayo, Harvard, and Dartmouth medical schools, and real-world expertise spanning diabetes, rare endocrine disorders, obesity, thyroid disease, bone health, and cardiovascular-metabolic medicine. Executive Leadership: SVP and VP-level roles in Global and US Medical Affairs at four major pharmaceutical companies (Crinetics, Amgen, J&J/Janssen, Sanofi), spanning Oncology, Immunology, Neuroscience, Cardiovascular, Metabolic, and Rare Disease therapeutic areas — and service as CEO of a gene therapy company reporting directly to a Board of Directors. Global Education & Research: Medical Director of the WHO Collaborating Center for Diabetes Education; trained endocrinologists across 20+ countries; Principal Investigator on NIH-NIDDK/NHLBI federally funded trials (ACCORD, DCCT-EDIC); author of 35+ peer-reviewed publications in Lancet, Diabetes Care, JCEM, and other leading journals.Actively seeking Board of Directors positions in biotech/pharmaceutical industry.Key therapeutic expertise: Endocrinology · Rare/Orphan Diseases · Oncology · Cardiometabolic · Neuroscience · Immunology · Gene Therapy · BiosimilarsFunctional expertise: Medical Affairs · Clinical Development · Health Economics & Outcomes · KOL Strategy · Medical Education · Regulatory Strategy · Corporate Governance · P&L Accountability